Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315705344> ?p ?o ?g. }
- W4315705344 endingPage "322.e7" @default.
- W4315705344 startingPage "304" @default.
- W4315705344 abstract "Immune checkpoint blockade (ICB) can produce durable responses against cancer. We and others have found that a subset of patients experiences paradoxical rapid cancer progression during immunotherapy. It is poorly understood how tumors can accelerate their progression during ICB. In some preclinical models, ICB causes hyperprogressive disease (HPD). While immune exclusion drives resistance to ICB, counterintuitively, patients with HPD and complete response (CR) following ICB manifest comparable levels of tumor-infiltrating CD8+ T cells and interferon γ (IFNγ) gene signature. Interestingly, patients with HPD but not CR exhibit elevated tumoral fibroblast growth factor 2 (FGF2) and β-catenin signaling. In animal models, T cell-derived IFNγ promotes tumor FGF2 signaling, thereby suppressing PKM2 activity and decreasing NAD+, resulting in reduction of SIRT1-mediated β-catenin deacetylation and enhanced β-catenin acetylation, consequently reprograming tumor stemness. Targeting the IFNγ-PKM2-β-catenin axis prevents HPD in preclinical models. Thus, the crosstalk of core immunogenic, metabolic, and oncogenic pathways via the IFNγ-PKM2-β-catenin cascade underlies ICB-associated HPD." @default.
- W4315705344 created "2023-01-12" @default.
- W4315705344 creator A5003259124 @default.
- W4315705344 creator A5003311852 @default.
- W4315705344 creator A5005093063 @default.
- W4315705344 creator A5006253019 @default.
- W4315705344 creator A5014871240 @default.
- W4315705344 creator A5020206160 @default.
- W4315705344 creator A5021394498 @default.
- W4315705344 creator A5023622812 @default.
- W4315705344 creator A5027649222 @default.
- W4315705344 creator A5031785786 @default.
- W4315705344 creator A5032271799 @default.
- W4315705344 creator A5035752387 @default.
- W4315705344 creator A5036533952 @default.
- W4315705344 creator A5044876102 @default.
- W4315705344 creator A5045335075 @default.
- W4315705344 creator A5046011924 @default.
- W4315705344 creator A5050235042 @default.
- W4315705344 creator A5050868515 @default.
- W4315705344 creator A5051824786 @default.
- W4315705344 creator A5053441903 @default.
- W4315705344 creator A5054960097 @default.
- W4315705344 creator A5067842907 @default.
- W4315705344 creator A5072368632 @default.
- W4315705344 creator A5075804518 @default.
- W4315705344 creator A5086192108 @default.
- W4315705344 creator A5087704838 @default.
- W4315705344 creator A5088147590 @default.
- W4315705344 date "2023-02-01" @default.
- W4315705344 modified "2023-10-18" @default.
- W4315705344 title "Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy" @default.
- W4315705344 cites W1498931318 @default.
- W4315705344 cites W1578291413 @default.
- W4315705344 cites W1968139563 @default.
- W4315705344 cites W1984484036 @default.
- W4315705344 cites W1988476050 @default.
- W4315705344 cites W1989674299 @default.
- W4315705344 cites W1997081071 @default.
- W4315705344 cites W2006419043 @default.
- W4315705344 cites W2007649418 @default.
- W4315705344 cites W2016535776 @default.
- W4315705344 cites W2019607817 @default.
- W4315705344 cites W2034269086 @default.
- W4315705344 cites W2043746859 @default.
- W4315705344 cites W2053353274 @default.
- W4315705344 cites W2078510083 @default.
- W4315705344 cites W2089112805 @default.
- W4315705344 cites W2094464106 @default.
- W4315705344 cites W2100260504 @default.
- W4315705344 cites W2101571970 @default.
- W4315705344 cites W2102673471 @default.
- W4315705344 cites W2103190171 @default.
- W4315705344 cites W2106204137 @default.
- W4315705344 cites W2107429737 @default.
- W4315705344 cites W2108564378 @default.
- W4315705344 cites W2117692326 @default.
- W4315705344 cites W2120246444 @default.
- W4315705344 cites W2125836344 @default.
- W4315705344 cites W2130503287 @default.
- W4315705344 cites W2136054684 @default.
- W4315705344 cites W2143772132 @default.
- W4315705344 cites W2158021558 @default.
- W4315705344 cites W2223535266 @default.
- W4315705344 cites W2292383635 @default.
- W4315705344 cites W2293531514 @default.
- W4315705344 cites W2398131194 @default.
- W4315705344 cites W2516058590 @default.
- W4315705344 cites W2522313999 @default.
- W4315705344 cites W2554618897 @default.
- W4315705344 cites W2557336488 @default.
- W4315705344 cites W2558219863 @default.
- W4315705344 cites W2587048937 @default.
- W4315705344 cites W2601621622 @default.
- W4315705344 cites W2605497049 @default.
- W4315705344 cites W2736476343 @default.
- W4315705344 cites W2741363425 @default.
- W4315705344 cites W2761575992 @default.
- W4315705344 cites W2782949806 @default.
- W4315705344 cites W2782998220 @default.
- W4315705344 cites W2783708539 @default.
- W4315705344 cites W2796153225 @default.
- W4315705344 cites W2802731336 @default.
- W4315705344 cites W2891266481 @default.
- W4315705344 cites W2891951654 @default.
- W4315705344 cites W2910102155 @default.
- W4315705344 cites W2912870841 @default.
- W4315705344 cites W2914472860 @default.
- W4315705344 cites W2925446385 @default.
- W4315705344 cites W2935797142 @default.
- W4315705344 cites W2943793201 @default.
- W4315705344 cites W2943875279 @default.
- W4315705344 cites W2949453788 @default.
- W4315705344 cites W2949640269 @default.
- W4315705344 cites W2958014316 @default.
- W4315705344 cites W2964014383 @default.
- W4315705344 cites W2966465234 @default.
- W4315705344 cites W2967466156 @default.